{"id":"b9fc7d4d-c616-5c5e-a156-5cd25e6628cd","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-platelet-nos","predicate":"increases","statement":"Nitric oxide synthase activity was acutely increased in patients’ platelets after treatment and remained elevated for at least 20 hours.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"b854ff6c-c096-5afd-8371-dcfddb7c2952","mechanism_event_label":"The enzyme that releases the cells stays switched on well after the session ends.","subject":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"object":{"id":"0abceb92-01b0-55d2-843c-1c632bd18cef","slug":"platelet-nos-activity","display_name":"Platelet nitric oxide synthase activity","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"b854ff6c-c096-5afd-8371-dcfddb7c2952","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-platelet-nos-event","event_type":"observed_intervention","label":"The enzyme that releases the cells stays switched on well after the session ends.","description":"Nitric oxide synthase activity was acutely increased in patients’ platelets after treatment and remained elevated for at least 20 hours.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8a9c57f6-eafd-5243-afaf-d4e830939c4b","slug":"nos3","display_name":"Human endothelial nitric oxide synthase / eNOS / NOS3","entity_type_key":"protein"},"role":"measured_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"0abceb92-01b0-55d2-843c-1c632bd18cef","slug":"platelet-nos-activity","display_name":"Platelet nitric oxide synthase activity","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/hbot-research/21362081.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a830ae6900d884b73f4e5eac335263db6f9d981a0f95aa45ad3e266c44800e0b\", \"start_char\": 0, \"end_char\": 1077, \"text_sha256\": \"a830ae6900d884b73f4e5eac335263db6f9d981a0f95aa45ad3e266c44800e0b\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Diabetic patients undergoing hyperbaric oxygen for refractory neuropathic ulcers, with wound margin biopsies","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Clinical hyperbaric oxygen therapy courses for refractory lower-extremity ulcers","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Human observational measurements within a treatment course, without a randomised comparison. Protein content is measured in the mobilised cells, not in healed tissue.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The enzyme that releases the cells stays switched on well after the session ends.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[hbot-p21362081] Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. (2011). https://pubmed.ncbi.nlm.nih.gov/21362081/ DOI: 10.1111/j.1524-475x.2010.00660.x","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Peripheral blood, platelets and skin wound margins","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"634e4a05-62be-51a8-8f09-1f27438e6a5f","evidence_kind":"source_excerpt","locator":"Lines 608-619","start_line":608,"end_line":619,"excerpt":"### hbot-platelet-nos\nNitric oxide synthase activity was acutely increased in patients’ platelets after treatment and remained elevated for at least 20 hours.\nCondition category: normal\nnutrient_topic: Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.\nplain_language: The enzyme that releases the cells stays switched on well after the session ends.\norganism: Human\ntissue_or_cell_type: Peripheral blood, platelets and skin wound margins\nexperimental_model: Diabetic patients undergoing hyperbaric oxygen for refractory neuropathic ulcers, with wound margin biopsies\nlimitations: Human observational measurements within a treatment course, without a randomised comparison. Protein content is measured in the mobilised cells, not in healed tissue.\nexposure: Clinical hyperbaric oxygen therapy courses for refractory lower-extremity ulcers\nevidence_span: {\"source_cache\": \"artifacts/hbot-research/21362081.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a830ae6900d884b73f4e5eac335263db6f9d981a0f95aa45ad3e266c44800e0b\", \"start_char\": 0, \"end_char\": 1077, \"text_sha256\": \"a830ae6900d884b73f4e5eac335263db6f9d981a0f95aa45ad3e266c44800e0b\"}\n[hbot-p21362081] Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. (2011). https://pubmed.ncbi.nlm.nih.gov/21362081/ DOI: 10.1111/j.1524-475x.2010.00660.x","model_system":"Diabetic patients undergoing hyperbaric oxygen for refractory neuropathic ulcers, with wound margin biopsies","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [hbot-p21362081] Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. (2011). https://pubmed.ncbi.nlm.nih.gov/21362081/ DOI: 10.1111/j.1524-475x.2010.00660.x","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dbf39b48-c95e-5291-b404-349ffbc4488f","stable_key":"import-488ea171-36b8-5ef6-b5d3-98563980fdbf","title":"Hyperbaric oxygen: the exposure, its reactive species, the signals they carry, and the nutrient-dependent enzymes that handle them (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"fb2443321804010d82c6b96ab61cc51b4b6628ddbb15751cb0e90b491606e79c","revision_id":"bb699ea5-b492-5728-b22c-48f0842a8ac9","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}